Evidence map›Paper›PMID 21062367›Full record

ReviewTransplant international : official journal of the European Society for Organ Transplantation2011

Regenerative medicine as applied to solid organ transplantation: current status and future challenges.

Giuseppe Orlando, Pedro Baptista, Martin Birchall, Paolo De Coppi, Alan Farney, Nadia K Guimaraes-Souza, Emmanuel Opara, Jeffrey Rogers, Dror Seliktar, Keren Shapira-Schweitzer and 4 more

Abstract readReview
In one paragraph

Review in Transplant international : official journal of the European Society for Organ Transplantation, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Regenerative medicine technologies applied to transplant medicine. An update.Frontiers in bioengineering and biotechnology · 2022
    Review
  5. Article
  6. Bioprinting for Liver Transplantation.Bioengineering (Basel, Switzerland) · 2019
    Review
  7. Review
  8. Translational medical research and liver transplantation: systematic review.Translational gastroenterology and hepatology · 2018
    Review
  9. Article
  10. Article
  11. Advances in the Knowledge about Kidney Decellularization and Repopulation.Frontiers in bioengineering and biotechnology · 2017
    Review
  12. Review
  13. Article
  14. New Phase of Growth for Xenogeneic-Based Bioartificial Organs.International journal of molecular sciences · 2016
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Regenerative Medicine in Organ and Tissue Transplantation: Shortly and Practically Achievable?International journal of organ transplantation medicine · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Giuseppe OrlandoTransplantation Research Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK. gorlando@wfubmc.edu
Pedro Baptista
Martin Birchall
Paolo De Coppi
Alan Farney
Nadia K Guimaraes-Souza
Emmanuel Opara
Jeffrey Rogers
Dror Seliktar
Keren Shapira-Schweitzer
Robert J Stratta
Anthony Atala
Kathryn J Wood
Shay Soker

Funding

Bioengineering A Bioartificial PancreasR01DK080897 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI OPARA, EMMANUEL C. · 2009 to 2010
$1.0M
NIDDK NIH HHS R01 DK080897
6 · The paper itself

Abstract

In the last two decades, regenerative medicine has shown the potential for "bench-to-bedside" translational research in specific clinical settings. Progress made in cell and stem cell biology, material sciences and tissue engineering enabled researchers to develop cutting-edge technology which has lead to the creation of nonmodular tissue constructs such as skin, bladders, vessels and upper airways. In all cases, autologous cells were seeded on either artificial or natural supporting scaffolds. However, such constructs were implanted without the reconstruction of the vascular supply, and the nutrients and oxygen were supplied by diffusion from adjacent tissues. Engineering of modular organs (namely, organs organized in functioning units referred to as modules and requiring the reconstruction of the vascular supply) is more complex and challenging. Models of functioning hearts and livers have been engineered using "natural tissue" scaffolds and efforts are underway to produce kidneys, pancreata and small intestine. Creation of custom-made bioengineered organs, where the cellular component is exquisitely autologous and have an internal vascular network, will theoretically overcome the two major hurdles in transplantation, namely the shortage of organs and the toxicity deriving from lifelong immunosuppression. This review describes recent advances in the engineering of several key tissues and organs.

Indexed as

Organ TransplantationRegenerative MedicineAnimalsBioengineeringCorneal TransplantationGastrointestinal TractHeartHumansIntestinesKidneyKidney TransplantationLiverLiver TransplantationPancreasPancreas TransplantationRegeneration

Identifiers

PMID21062367
PMCPMC3817209

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.